Anyone else evaluating the newly cleared cartridge-based POC PCR platforms? We ran a side-by-side last Tuesday on 60 de-identified specimens and saw 98.7% positive agreement and 99.5% negative agreement versus our central lab RT‑PCR, with onboard QC and LIS/Wi‑Fi connectivity — wondering if that accuracy and plug‑and‑play setup is moving the needle in your territories.
Numbers look strong; even if it’s plug‑and‑play, my buyers still ask about the ‘electric bill’ — all‑in cost/test and the invalid rate. I’d run a 2‑week urgent care pilot tracking time‑to‑result and cartridge spoilage and confirm CLIA‑waived status here: https://www.fda.gov/medical-devices/ivd-categorization-and-clia-waived-tests — what per‑test cost did you see?
After our 60‑specimen Tuesday run, the real lever was throughput: single‑module units queued badly, while a 4‑bay cleared a lunch rush in about 40 minutes. I’d demo that and confirm the LIS/Wi‑Fi isn’t paywalled — HL7 interface fees have stalled my deals even with “onboard QC.” Seeing vendors commit to 24‑hr swap stock on heater failures has been the difference in my last two deals, @julian_clark92.